To include your compound in the COVID-19 Resource Center, submit it here.

BioNTech will do without $100M from Hong Kong-based series B investor

An updated IPO prospectus revealed that BioNTech no longer expects a $100 million contribution to its previously announced series B round from an undisclosed Hong Kong-based investor.

The company's initial IPO filing on Sept. 10 had said BioNTech SE was still waiting on

Read the full 428 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers